Suppliers Say IG Report On Home-Infusion Reimbursement Is Misleading

The HHS Inspector General reports that the reimbursement scheme for home infusion inappropriately drives up the use of drugs by paying suppliers too much, but the National Home Infusion Association says the pay scheme doesn't drive overuse because physicians, not suppliers, prescribe drugs. CMS officials tell the Inspector General they are considering phasing in competitive bidding for home infusion drugs, which would cut pay rates. Medicare pays doctors 106 percent of the average sales price for the vast majority of...